Visa stock stuck near $326 as crypto off-ramp deal and Jan. 29 earnings loom
24 January 2026
1 min read

Visa stock stuck near $326 as crypto off-ramp deal and Jan. 29 earnings loom

New York, Jan 24, 2026, 06:34 ET — Market closed

  • Visa closed Friday down just 0.06%, holding steady ahead of a crucial earnings report
  • Visa Direct’s latest crypto-to-cash deal shifts the narrative
  • Traders eye consumer spending signals alongside risks tied to card-fee policies

Visa Inc shares closed Friday nearly unchanged, slipping just 0.06% to $326.18. 1

With U.S. markets closed for the weekend, focus turns to Visa’s upcoming results next week—a key indicator of consumer spending and cross-border travel trends. Investors view the network mainly through the lens of transaction volume, not lending, so shifts in payment activity can quickly impact the stock.

Visa grabbed fresh headlines Thursday as crypto payments platform Mercuryo announced it will tap Visa Direct to let users convert digital tokens into fiat currency and send funds to Visa cards — known in the industry as “off-ramping.” Mercuryo CEO Petr Kozyakov said the partnership “makes it easier to convert digital token balances into fiat.” Anastasia Serikova, Visa Direct Europe head, called the move “building bridges between the crypto space and the traditional financial system.” Still, policy risks remain: the Credit Card Competition Act aims to force major issuers to add at least two unaffiliated networks, expanding routing options for merchants. 2

Friday’s action saw a split tape. The Dow dropped roughly 0.6%, while the S&P 500 hovered near flat. Investors mulled over tech earnings, geopolitical developments, and the looming Fed decision. 3

JP Morgan analyst Tien-tsin Huang sees recent spending data signaling “only a slight slowdown” in Q4, maintaining that the domestic consumer remains solid. He noted that while headlines around the Credit Card Competition Act have made investors wary, any effect should be manageable. Huang projects Visa’s net revenue at $10.67 billion and earnings per share at $3.12 for the fiscal first quarter. 4

Visa edged up 0.33% on Thursday before retreating on Friday. The shares fluctuated between $324.62 and $327.80 during Friday’s session, with roughly 5.7 million shares traded. 5

Peers showed bigger moves. Mastercard slid 1.52%, while American Express lost 1.72% on Friday, a day when the S&P 500 nudged up but the Dow slipped. 6

Investors tuning in to Visa’s report will focus on volume trends, cross-border expansion, and any changes in pricing or costs. Comments on Visa Direct and other “new flows” beyond card swipes will be closely watched, as they shed light on growth beyond the usual consumer card spending.

But the risk remains. A sharper drop in spending, a stronger dollar cutting returns from abroad when converted back into U.S. dollars, or fresh push in Washington for routing mandates could all weigh on sentiment and dampen fee-growth forecasts.

Visa is set to release its fiscal first-quarter earnings after the market closes on Jan. 29. The company will follow up with a conference call at 5 p.m. ET, it announced. 7

Stock Market Today

Applied Digital stock jumps 25% as AI data-center names rebound — what’s next for APLD

Applied Digital stock jumps 25% as AI data-center names rebound — what’s next for APLD

7 February 2026
Applied Digital Corporation shares jumped 25.52% Friday to $34.95, then slipped to $34.60 after hours. The company reported fiscal Q2 revenue up 250% to $126.6 million and signed leases for 600 MW of data center capacity in North Dakota. Applied Digital broke ground on a new 430‑MW campus in the southern U.S. in January. Financing includes a $100 million promissory note with 8% interest, paid in kind.
Eli Lilly stock pops as FDA targets cheap weight-loss copycats — what to know before Monday

Eli Lilly stock pops as FDA targets cheap weight-loss copycats — what to know before Monday

7 February 2026
Eli Lilly shares rose 3.7% to $1,058.18 Friday after the FDA said it would act against telehealth firm Hims & Hers for marketing a $49 compounded weight-loss pill. The move followed a sharp selloff Thursday when Hims announced plans to sell a version of Novo Nordisk’s Wegovy. Investors remain uncertain how aggressively regulators will police copycat drugs and pricing in the obesity drug market.
Costco stock (COST) holds near $1,000 as dividend date nears and a sales update looms
Previous Story

Costco stock (COST) holds near $1,000 as dividend date nears and a sales update looms

TMC stock jumps 13% on NOAA deep-sea mining permit filing — key dates traders watch next week
Next Story

TMC stock jumps 13% on NOAA deep-sea mining permit filing — key dates traders watch next week

Go toTop